SPHDF
SANTHERA PHARMS HLDGS LTD by Santhera Pharmaceuticals Holdings Ltd. (SPHDF)
$54
About SANTHERA PHARMS HLDGS LTD by Santhera Pharmaceuticals Holdings Ltd. (SPHDF)
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$17.54
52 Week Low
$9.42
Market cap
220.9M
Dividend yield
0.00%
Volume
--
Avg. volume
106
P/E ratio
2.62
SANTHERA PHARMS HLDGS LTD by Santhera Pharmaceuticals Holdings Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$17.54
52 Week Low
$9.42
Market cap
220.9M
Dividend yield
0.00%
Volume
--
Avg. volume
106
P/E ratio
2.62